Berlin

• Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome … Ended
  2024-511628-16-00 4 2024-07-18 Post Covid Syndrome (PCS)
• Evaluation of ELX/TEZ/IVA in Cystic Fibrosis Subjects 12 to Less Than 24 Months of Age Ended
  2023-503230-49-00 5 2024-07-16 Cystic Fibrosis
• A study to investigate the effect of oral ticagrelor on the pharmacokinetics of oral rosuvastatin when given in healthy participants Ended
  2024-512197-99-00 3 2024-07-12 Clinical trial healthy volunteer
• A Phase 4 Multicenter, Randomized, Open-label, Efficacy Assessor-blinded Study of Risankizumab Compared to Deucravacitinib for the Treatment … Ended
  2023-509738-20-00 6 2024-07-11 Plaque Psoriasis
• A research study looking into the effect of NNC05190130 on blood levels of a birth control pill and emptying of the stomach in women after m … Ended
  2023-507973-16-00 3 2024-07-04 Healthy postmenopausal females (Type 2 Diabetes)
• Phase 2a, double-blind, randomized, placebo-controlled trial of methylprednisolone versus placebo in patients with cognitive deficits in pos … Ended
  2023-504826-21-00 4 2024-07-02 Post COVID-19 Syndrome
• Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction Ended
  2023-506210-40-00 5 2024-06-28 Heart Failure due to Systemic Left Ventricular Systolic Dysfunction
• An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal … Ended
  2023-507350-33-00 5 2024-06-25 Thyroid eye disease
• An Open-label, Single-group, Three-period, Fixed-sequence, Phase I Study to Assess the Pharmacokinetics of AZD6793 Tablets When Administered … Ended
  2023-509002-30-00 3 2024-06-25 Chronic obstructive pulmonary disease
• A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended
  2024-511076-32-00 6 2024-06-21 Hypercholesterolemia
• A safety study of PF-08046045/SGN-35T in adults with advanced cancers Ended
  2022-502390-41-00 1 2024-06-20 Enteropathy-Associated T-Cell Lymphoma
• A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants with Severe Asthma (VALIANT) Ended
  2023-507410-27-00 4 2024-06-19 Severe Asthma
• A Proof-of-Concept study to assess the efficacy, safety and tolerability of itepekimab (anti-IL-33 mAb) in participants with non-cystic fibr … Ended
  2023-508663-70-00 4 2024-06-18 Bronchiectasis
• Multiple Ascending Doses of BMS-986326 in Participants with Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, or Systemic … Ended
  2022-503009-39-00 3 2024-06-04 Subacute Cutaneous Lupus Erythematosus
• A Two-Part Study to Assess the Effectiveness, Safety, and Blood Levels of Repeat Doses of Inhaled ETD001 in People with Cystic Fibrosis Ended
  2023-504092-25-00 4 2024-06-04 Cystic Fibrosis
• A randomized, open label, multicenter phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic, refractory col … Ended
  2023-509771-17-00 10 2024-06-04 Metastatic Colorectal cancer (mCRC)
• A study on the immune response and safety of vaccine against respiratory syncytial virus given to adults 18 to 49 years of age at increased … Ended
  2023-510190-34-00 5 2024-06-04 Respiratory Syncytial Virus Infections
• Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants Ended
  2023-506407-26-00 1 2024-05-28 Clostridioides difficile (C. difficile)
• A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food Ended
  2023-509889-38-00 3 2024-05-28 Healthy volunteer trial
• A Phase IIb, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Po … Ended
  2022-500410-26-01 4 2024-05-27 Cystic Fibrosis
• A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Ended
  2022-502481-24-00 4 2024-05-23 Chronic Rhinosinusitis without Nasal Polyps (CRSsNP)
• A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body Ended
  2023-509950-67-00 2 2024-05-23 Pharmacokinetic trial
• [68Ga]Ga-PentixaFor-PET imaging for staging of marginal zone lymphoma Ended
  2022-500918-25-00 5 2024-05-20 Marginal Zone Lymphoma
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants with Moderate to Severe Ulcerative Colitis Ended
  2023-506655-19-00 4 2024-05-16 Ulcerative Colitis (UC)

Showing 1,393–1,416 of 1,776 trials